Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia von Shi, Y, Tomic, J, Wen, F, Shaha, S, Bahlo, A, Harrison, R, Dennis, J W, Williams, R, Gross, B J, Walker, S, Zuccolo, J, Deans, J P, Hart, G W, Spaner, D E

Volltext

Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia von SPANER, D. E, MASELLIS, A

Volltext

PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia von Spaner, D E, Lee, E, Shi, Y, Wen, F, Li, Y, Tung, S, McCaw, L, Wong, K, Gary-Gouy, H, Dalloul, A, Ceddia, R, Gorzcynski, R

Volltext

Oral high-dose glucocorticoids and Ofatumumab in fludarabine-resistant Chronic Lymphocytic Leukemia von Spaner, D E

Volltext

PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions von Wang, X, Wang, G, Shi, Y, Sun, L, Gorczynski, R, Li, Y-J, Xu, Z, Spaner, D E

Volltext

A role for Danazol in chronic lymphocytic leukemia von Tung, S, Spaner, D E

Volltext

A phase I II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia von Spaner, D E, Shi, Y, White, D, Shaha, S, He, L, Masellis, A, Wong, K, Gorczynski, R

Volltext

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells von SPANER, D. E, SHI, Y, RADVANYI, L, WHITE, D, MENA, J, HAMMOND, C, TOMIC, J, HE, L, TOMAI, M. A, MILLER, R. L, BOOTH, J

Volltext

Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells von Shaha, S.P, Tomic, J, Shi, Y, Pham, T, Mero, P, White, D, He, L, Baryza, J.L, Wender, P.A, Booth, J.W, Spaner, D.E

Volltext

Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2 neu overexpressing tumor model von Felizardo, T C, Wang, J C M, McGray, R A J, Evelegh, C, Spaner, D E, Fowler, D H, Bramson, J L, Medin, J A

Volltext

PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells von Sun, L, Shi, Y, Wang, G, Wang, X, Zeng, S, Dunn, S E, Fairn, G D, Li, Y-J, Spaner, D E

Volltext

PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions von Li, Y-J, Sun, L, Shi, Y, Wang, G, Wang, X, Dunn, S E, Iorio, C, Screaton, R A, Spaner, D E

Volltext

A role for oleoylethanolamide in chronic lymphocytic leukemia von Masoodi, M, Lee, E, Eiden, M, Bahlo, A, Shi, Y, Ceddia, R B, Baccei, C, Prasit, P, Spaner, D E

Volltext

Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies von Spaner, D E, Foley, R, Galipeau, J, Bramson, J

Volltext

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab von Berinstein, N. L., Bhella, S., Pennell, N. M., Cheung, M. C., Imrie, K. R., Spaner, D. E., Milliken, V., Zhang, L., Hewitt, K., Boudreau, A., Reis, M. D., Chesney, A., Good, D., Ghorab, Z., Hicks, L. K., Piliotis, E., Buckstein, R.

Volltext

The B-cell calcium sensor predicts progression of chronic lymphocytic leukemia von Hammond, C M, Shi, Y, White, D, Cervi, D, Tomic, J, Spaner, D E

Volltext

Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial von Spaner, David E, Wang, Guizhei, McCaw, Lindsay, Li, Yanmei, Disperati, Patricia, Cussen, Mary-Ann, Shi, Yonghong

Volltext

The scid Mouse: Mutation in a DNA Repair Gene Creates Recipients Useful for Studies on Stem Cells, Lymphocyte Development and Graft-versus-Host Disease von Phillips, Robert A., Spaner, David E.

Volltext

Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies: Toll-like receptors in cancer von SPANER, D. E, FOLEY, R, GALIPEAU, J, BRAMSON, J

Volltext

Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells von Spaner, David E.

Volltext